A detailed history of Sentry LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sentry LLC holds 6,724 shares of ABT stock, worth $794,306. This represents 0.15% of its overall portfolio holdings.

Number of Shares
6,724
Previous 6,724 -0.0%
Holding current value
$794,306
Previous $699 Million 9.72%
% of portfolio
0.15%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

BUY
$90.19 - $110.4 $606,437 - $742,329
6,724 New
6,724 $740,000
Q1 2023

Mar 06, 2024

BUY
$96.86 - $114.01 $13,560 - $15,961
140 Added 2.08%
6,864 $695 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sentry LLC Portfolio

Follow Sentry LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry LLC with notifications on news.